Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ampio Pharmaceuticals (AMPE) stocks in Canada

Learn how to easily invest in Ampio Pharmaceuticals stocks.

Ampio Pharmaceuticals is a biotechnology business based in the US. Ampio Pharmaceuticals stocks (AMPE.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $1.62 – an increase of 11.1% over the previous week. Ampio Pharmaceuticals employs 18 staff and has a market cap (total outstanding stock value) of $112.2 million.

How to buy shares in Ampio Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMPE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Ampio Pharmaceuticals stock price (NYSE MKT:AMPE)

Use our graph to track the performance of AMPE stocks over time.

Ampio Pharmaceuticals shares at a glance

Information last updated 2022-01-17.
Latest market close$0.53
52-week range$0.48 - $2.59
50-day moving average $0.92
200-day moving average $1.47
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.08

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Ampio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Ampio Pharmaceuticals price performance over time

Historical closes compared with the close of $0.5333 from 2022-01-19

1 week (2022-01-13) 11.10%
1 month (2021-12-17) -24.89%
3 months (2021-10-19) -67.28%
6 months (2021-07-20) -64.45%
1 year (2021-01-20) -64.45%
2 years (2020-01-17) -17.80%
3 years (2019-01-18) 4.57%
5 years (2017-01-20) 0.945

Ampio Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -50.15%
Return on equity TTM -110.49%
Profit margin 0%
Book value $0.09
Market capitalisation $112.2 million

TTM: trailing 12 months

Ampio Pharmaceuticals share dividends

We're not expecting Ampio Pharmaceuticals to pay a dividend over the next 12 months.

Have Ampio Pharmaceuticals's shares ever split?

Ampio Pharmaceuticals's shares were split on a 2:7 basis on 31 July 2008. So if you had owned 7 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Ampio Pharmaceuticals shares – just the quantity. However, indirectly, the new 250% higher share price could have impacted the market appetite for Ampio Pharmaceuticals shares which in turn could have impacted Ampio Pharmaceuticals's share price.

Ampio Pharmaceuticals share price volatility

Over the last 12 months, Ampio Pharmaceuticals's shares have ranged in value from as little as $0.48 up to $2.59. A popular way to gauge a stock's volatility is its "beta".

AMPE.US volatility(beta: 1.49)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharmaceuticals's is 1.4876. This would suggest that Ampio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ampio Pharmaceuticals overview

Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site